Gossamer Bio Inc.

NASDAQ: GOSS · Real-Time Price · USD
1.97
0.01 (0.51%)
At close: Aug 15, 2025, 3:59 PM
1.94
-1.27%
After-hours: Aug 15, 2025, 05:04 PM EDT

Gossamer Bio Cash Flow Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
Net Income
-56.53M -179.82M -229.38M -234M
Depreciation & Amortization
4.15M 4.38M 4.43M 5.17M
Stock-Based Compensation
20.62M 28.52M 42.55M 32.01M
Other Working Capital
41.12M -18.83M -2.65M 5.2M
Other Non-Cash Items
-11.17M 2.6M -177K 6.81M
Deferred Income Tax
n/a n/a n/a 359K
Change in Working Capital
39.46M -14.84M -4.46M 774K
Operating Cash Flow
-3.47M -159.16M -187.03M -188.89M
Capital Expenditures
n/a n/a -475K -1.62M
Cash Acquisitions
n/a n/a -65K 75K
Purchase of Investments
-494.78M -441.67M -238.06M -152.03M
Sales Maturities Of Investments
523.8M 330.7M 237.5M 36.23M
Other Investing Acitivies
n/a n/a 65K -75K
Investing Cash Flow
29.02M -110.97M -1.03M -117.43M
Debt Repayment
-12.58M -11.61M -5.81M n/a
Common Stock Repurchased
629K n/a n/a n/a
Dividend Paid
n/a n/a n/a n/a
Other Financial Acitivies
1.09M 444K 2.95M 3.33M
Financial Cash Flow
-11.49M 190.15M 117.09M 3.33M
Net Cash Flow
13.96M -79.86M -71.49M -303.15M
Free Cash Flow
-3.47M -159.16M -187.51M -190.51M